In the dynamic world of pharmaceutical marketing, staying ahead of the curve is essential for success. As technology continues to evolve, so do the opportunities for innovative campaigns. One area where pharma marketers can make a significant impact is in raising awareness about non-communicable diseases (NCDs) and promoting real-world studies and clinical trials.

The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.

One of the many ways of influencing patients to...

India's top 10 pharma companies by market capitalization, offering insights into...

A large part of the pharma houses continues to...

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...